Paper

Hemodynamic effects of intravenous sematilide in patients with congestive heart failure: a class III antiarrhythmic agent without cardiodepressant effects.

Published Dec 1, 1995 · DOI · B. Stambler, S. Gottlieb, B. Singh

Journal of the American College of Cardiology

Citations

Influential Citations

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

Non-RCT

Study Snapshot

Intravenous sematilide, a class III antiarrhythmic agent, does not cause cardiodepressant effects but may be proarrhythmic in patients with congestive heart failure.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Hemodynamic effects of intravenous sematilide in patients with congestive heart failure: a class III antiarrhythmic agent without cardiodepressant effects.

References

Citations